Logo image of ALBKK.PA

BAIKOWSKI SAS (ALBKK.PA) Stock Fundamental Analysis

EPA:ALBKK - Euronext Paris - Matif - FR0013384369 - Common Stock - Currency: EUR

16.5  -0.2 (-1.2%)

Fundamental Rating

3

ALBKK gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 63 industry peers in the Chemicals industry. ALBKK has only an average score on both its financial health and profitability. ALBKK has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year ALBKK was profitable.
In the past year ALBKK had a positive cash flow from operations.
Each year in the past 5 years ALBKK has been profitable.
ALBKK had a positive operating cash flow in each of the past 5 years.
ALBKK.PA Yearly Net Income VS EBIT VS OCF VS FCFALBKK.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M 6M 8M 10M

1.2 Ratios

Looking at the Return On Assets, with a value of 0.99%, ALBKK is in line with its industry, outperforming 57.14% of the companies in the same industry.
ALBKK has a Return On Equity (1.54%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA 0.99%
ROE 1.54%
ROIC N/A
ROA(3y)7.15%
ROA(5y)5.46%
ROE(3y)11.21%
ROE(5y)9.06%
ROIC(3y)N/A
ROIC(5y)N/A
ALBKK.PA Yearly ROA, ROE, ROICALBKK.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15

1.3 Margins

With a Profit Margin value of 1.71%, ALBKK perfoms like the industry average, outperforming 57.14% of the companies in the same industry.
ALBKK's Profit Margin has declined in the last couple of years.
ALBKK's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 56.57%, ALBKK belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.
ALBKK's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 1.71%
GM 56.57%
OM growth 3Y-66.01%
OM growth 5Y-64.4%
PM growth 3Y-10.16%
PM growth 5Y-24.4%
GM growth 3Y4.34%
GM growth 5Y-11.34%
ALBKK.PA Yearly Profit, Operating, Gross MarginsALBKK.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 20 40 60

More info and screens

5

2. Health

2.1 Basic Checks

ALBKK does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALBKK has about the same amount of shares outstanding.
Compared to 5 years ago, ALBKK has about the same amount of shares outstanding.
ALBKK has a worse debt/assets ratio than last year.
ALBKK.PA Yearly Shares OutstandingALBKK.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M
ALBKK.PA Yearly Total Debt VS Total AssetsALBKK.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

2.2 Solvency

An Altman-Z score of 3.10 indicates that ALBKK is not in any danger for bankruptcy at the moment.
ALBKK has a better Altman-Z score (3.10) than 76.19% of its industry peers.
A Debt/Equity ratio of 0.15 indicates that ALBKK is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.15, ALBKK belongs to the top of the industry, outperforming 85.71% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Altman-Z 3.1
ROIC/WACCN/A
WACC6.8%
ALBKK.PA Yearly LT Debt VS Equity VS FCFALBKK.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 10M 20M 30M 40M

2.3 Liquidity

A Current Ratio of 1.95 indicates that ALBKK should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.95, ALBKK is in the better half of the industry, outperforming 61.90% of the companies in the same industry.
ALBKK has a Quick Ratio of 1.12. This is a normal value and indicates that ALBKK is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of ALBKK (1.12) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.95
Quick Ratio 1.12
ALBKK.PA Yearly Current Assets VS Current LiabilitesALBKK.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for ALBKK have decreased strongly by -87.08% in the last year.
The earnings per share for ALBKK have been decreasing by -26.80% on average. This is quite bad
ALBKK shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -18.38%.
The Revenue has been decreasing by -3.17% on average over the past years.
EPS 1Y (TTM)-87.08%
EPS 3Y-9.9%
EPS 5Y-26.8%
EPS Q2Q%-10.61%
Revenue 1Y (TTM)-18.38%
Revenue growth 3Y0.36%
Revenue growth 5Y-3.17%
Sales Q2Q%13.38%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALBKK.PA Yearly Revenue VS EstimatesALBKK.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M
ALBKK.PA Yearly EPS VS EstimatesALBKK.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 91.67, which means the current valuation is very expensive for ALBKK.
The rest of the industry has a similar Price/Earnings ratio as ALBKK.
ALBKK's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 29.35.
Industry RankSector Rank
PE 91.67
Fwd PE N/A
ALBKK.PA Price Earnings VS Forward Price EarningsALBKK.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

ALBKK's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. ALBKK is more expensive than 61.90% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 34.59
ALBKK.PA Per share dataALBKK.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

5

5. Dividend

5.1 Amount

ALBKK has a Yearly Dividend Yield of 3.64%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.09, ALBKK pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.33, ALBKK pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.64%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ALBKK.PA Yearly Dividends per shareALBKK.PA Yearly Dividends per shareYearly Dividends per share 2022 2023 0.2 0.4 0.6 0.8

5.3 Sustainability

ALBKK pays out 0.30% of its income as dividend. This is a sustainable payout ratio.
DP0.3%
EPS Next 2YN/A
EPS Next 3YN/A
ALBKK.PA Yearly Income VS Free CF VS DividendALBKK.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M 6M 8M
ALBKK.PA Dividend Payout.ALBKK.PA Dividend Payout, showing the Payout Ratio.ALBKK.PA Dividend Payout.PayoutRetained Earnings

More info and screens

BAIKOWSKI SAS

EPA:ALBKK (3/7/2025, 7:00:00 PM)

16.5

-0.2 (-1.2%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners9.25%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap60.72M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.64%
Yearly Dividend0.6
Dividend Growth(5Y)N/A
DP0.3%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 91.67
Fwd PE N/A
P/S 1.56
P/FCF N/A
P/OCF 28.15
P/B 1.39
P/tB 1.64
EV/EBITDA 34.59
EPS(TTM)0.18
EY1.09%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.34
FCFYN/A
OCF(TTM)0.59
OCFY3.55%
SpS10.6
BVpS11.84
TBVpS10.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.99%
ROE 1.54%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 1.71%
GM 56.57%
FCFM N/A
ROA(3y)7.15%
ROA(5y)5.46%
ROE(3y)11.21%
ROE(5y)9.06%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)7.9%
ROCE(5y)5.95%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-66.01%
OM growth 5Y-64.4%
PM growth 3Y-10.16%
PM growth 5Y-24.4%
GM growth 3Y4.34%
GM growth 5Y-11.34%
F-Score5
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Debt/EBITDA 3.22
Cap/Depr 109.37%
Cap/Sales 8.73%
Interest Coverage N/A
Cash Conversion 108.5%
Profit Quality N/A
Current Ratio 1.95
Quick Ratio 1.12
Altman-Z 3.1
F-Score5
WACC6.8%
ROIC/WACCN/A
Cap/Depr(3y)67.57%
Cap/Depr(5y)59.87%
Cap/Sales(3y)5.86%
Cap/Sales(5y)5.8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-87.08%
EPS 3Y-9.9%
EPS 5Y-26.8%
EPS Q2Q%-10.61%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-18.38%
Revenue growth 3Y0.36%
Revenue growth 5Y-3.17%
Sales Q2Q%13.38%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-123.5%
EBIT growth 3Y-65.88%
EBIT growth 5Y-65.53%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-115.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-78.01%
OCF growth 3Y-50.66%
OCF growth 5Y-35.54%